Actively Recruiting
Postprandial Glucose Levels, Gut Microbiota and Supplementation With Functional Foods in Adults
Led by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · Updated on 2025-06-18
200
Participants Needed
1
Research Sites
173 weeks
Total Duration
On this page
Sponsors
I
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Lead Sponsor
F
Fundación Gonzalo Río Arronte
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a clinical study with participants over 18 years of age that meet the selection criteria. This will be 42-day study divided into three phases of 14 days each: 14 days without intervention, 14 days with intervention with functional foods and 14 days without intervention again. With the objective of assess the changes in the postprandial glycemic responses through the gut microbiota and urine metabolites.
CONDITIONS
Official Title
Postprandial Glucose Levels, Gut Microbiota and Supplementation With Functional Foods in Adults
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male and female
- Adults between 18 and 60 years of age
- The signing of the informed consent
You will not qualify if you...
- Patients with any type of diabetes
- Patients with high blood pressure
- Patients with acquired diseases secondarily producing obesity and diabetes
- Patients who have suffered a cardiovascular event
- Patients with gastrointestinal diseases
- Weight loss > 3 kg in the last 3 months
- Catabolic diseases such as cancer and acquired immunodeficiency syndrome
- Pregnancy status
- Use of antihypertensive drugs or treatment (thiacycline, loop or potassium-sparing diuretics, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, alpha blockers, calcium antagonists, beta blockers)
- Treatment with hypoglycemic agents (sulfonylureas, biguanides, incretins) or insulin and antidiabetic drugs
- Treatment with statins, fibrates or other drugs to control dyslipidemia
- Use of antibiotics in the three months prior to the study
- Use of steroid drugs, chemotherapy, immunosuppressants, or radiation therapy
- Use of anorexigenic or weight loss accelerating drugs such as sibutramine or orlistat
- Supplements with any of the functional foods used in the study
- Use of probiotic, prebiotic or symbiotic supplements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Mexico City, Mexico City, Mexico, 14080
Actively Recruiting
Research Team
A
Armando R Tovar, Doctor
CONTACT
M
Martha Guevara-Cruz, Doctor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here